HALIFAX, Oct. 22, 2108 /PRNewswire/ – Adaptiiv, an innovative medical technology company announced today the University of Hong Kong will use 3D Bolus Software, an advanced software solution that enables the creation of customized personal medical devices using 3D printing, used primarily in the treatment of cancer. Additionally, Adaptiiv will partner with the University’s department of Clinical Oncology to develop new applications.

Adaptiiv is the first company in the world to receive FDA 510k clearance for 3D printing software used in radiation oncology. Founded in 1911, The University of Hong Kong is the territory’s oldest institute of higher learning and also an internationally recognized, research led, comprehensive university.

Read More